Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

(2015) Steven C. Lin et al.   Clinical Gastroenterology and Hepatology

Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis

(2015) Ahilan Arulanandan et al.   Clinical Gastroenterology and Hepatology

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

(2015) Rohit Loomba et al.   GASTROENTEROLOGY

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop

(2015) Arun J. Sanyal et al.   HEPATOLOGY

Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

(2015) Rohit Loomba et al.   HEPATOLOGY

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels

(2014) K. E. Corey et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study

(2014) Lisa B. VanWagner et al.   ATHEROSCLEROSIS

No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial

(2014) Arun J. Sanyal et al.   GASTROENTEROLOGY

Coronary Artery Calcium Score

(2014) Tamar S. Polonsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2014) Bruce Andrus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nonalcoholic fatty liver disease and vascular disease: State-of-the-art

(2014) Silvia Fargion   WORLD JOURNAL OF GASTROENTEROLOGY

Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA)

(2013) Arvind K. Pandey et al.   ATHEROSCLEROSIS

Progression of Coronary Calcium and Incident Coronary Heart Disease Events

(2013) Matthew J. Budoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

(2012) A. Zarrinpar et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

(2012) Geoffrey C. Farrell et al.   Gut and Liver

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial

(2012) Thuy-Anh Le et al.   HEPATOLOGY

Nonalcoholic fatty liver disease is associated with coronary artery calcification

(2012) Donghee Kim et al.   HEPATOLOGY

Fatty liver index, gamma-glutamyltransferase, and early carotid plaques

(2012) Michaela Kozakova et al.   HEPATOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals

(2012) Joseph Yeboah et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Framingham risk score and heart disease in nonalcoholic fatty liver disease

(2012) Sombat Treeprasertsuk et al.   LIVER INTERNATIONAL

Prediction of Coronary Artery Calcium Progression in Individuals With Low Framingham Risk Score

(2012) Tochi M. Okwuosa et al.   JACC-Cardiovascular Imaging

Effects of lifestyle modification on coronary artery calcium progression and prognostic factors in coronary patients—3-Year results of the randomized SAFE-LIFE trial

(2011) Nils Lehmann et al.   ATHEROSCLEROSIS

Genetic Covariance Between γ-Glutamyl Transpeptidase and Fatty Liver Risk Factors: Role of β2-Adrenergic Receptor Genetic Variation in Twins

(2010) Rohit Loomba et al.   GASTROENTEROLOGY

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

Coronary Artery Calcium Progression: An Important Clinical Measurement?

(2010) John W. McEvoy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heritability of Nonalcoholic Fatty Liver Disease

(2009) Jeffrey B. Schwimmer et al.   GASTROENTEROLOGY

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review

(2008) Silvia Sookoian et al.   JOURNAL OF HEPATOLOGY

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

(2008) Robert Detrano et al.   NEW ENGLAND JOURNAL OF MEDICINE